Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -32.0x - -35.3x | -33.6x |
| Selected Fwd P/E Multiple | 2,596.0x - 2,869.3x | 2,732.7x |
| Fair Value | $67.75 - $74.88 | $71.32 |
| Upside | -30.7% - -23.4% | -27.0% |
| Benchmarks | - | Full Ticker |
| Sight Sciences, Inc. | - | NasdaqGS:SGHT |
| IRIDEX Corporation | - | NasdaqCM:IRIX |
| Koninklijke Philips N.V. | - | NYSE:PHG |
| Nova Eye Medical Limited | - | OTCPK:ELXM.F |
| Alcon Inc. | - | NYSE:ALC |
| Glaukos Corporation | - | NYSE:GKOS |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| SGHT | IRIX | PHG | ELXM.F | ALC | GKOS | |||
| NasdaqGS:SGHT | NasdaqCM:IRIX | NYSE:PHG | OTCPK:ELXM.F | NYSE:ALC | NYSE:GKOS | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | 39.4% | NM- | ||
| Latest Twelve Months | 9.8% | 34.8% | 130.0% | 40.2% | 6.9% | 12.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -100.6% | -15.6% | 2.5% | 1.1% | 3.9% | -33.9% | ||
| Prior Fiscal Year | -68.5% | -18.5% | -2.5% | -89.8% | 10.3% | -42.8% | ||
| Latest Fiscal Year | -64.5% | -18.3% | -4.7% | -37.7% | 10.3% | -38.2% | ||
| Latest Twelve Months | -63.2% | -14.6% | 1.3% | -32.8% | 11.3% | -30.6% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -2.3x | -5.1x | 10.1x | -6.9x | 20.2x | -81.0x | ||
| Price / LTM Sales | 2.3x | 0.4x | 1.1x | 1.5x | 4.4x | 13.8x | ||
| LTM P/E Ratio | -3.7x | -3.0x | 84.5x | -4.5x | 38.7x | -45.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -4.5x | -3.0x | 84.5x | |||||
| Historical LTM P/E Ratio | -55.2x | -46.2x | -23.2x | |||||
| Selected P/E Multiple | -32.0x | -33.6x | -35.3x | |||||
| (x) LTM Net Income | (124) | (124) | (124) | |||||
| (=) Equity Value | 3,952 | 4,160 | 4,368 | |||||
| (/) Shares Outstanding | 57.1 | 57.1 | 57.1 | |||||
| Implied Value Range | 69.20 | 72.85 | 76.49 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 69.20 | 72.85 | 76.49 | 97.70 | ||||
| Upside / (Downside) | -29.2% | -25.4% | -21.7% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | SGHT | IRIX | PHG | ELXM.F | ALC | GKOS | |
| Value of Common Equity | 181 | 21 | 20,067 | 55 | 43,299 | 5,580 | |
| (/) Shares Outstanding | 51.7 | 16.8 | 948.0 | 358.5 | 495.7 | 57.1 | |
| Implied Stock Price | 3.50 | 1.26 | 21.17 | 0.15 | 87.35 | 97.70 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 0.86 | 1.54 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 3.50 | 1.26 | 24.60 | 0.10 | 87.35 | 97.70 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 0.86 | 1.54 | 1.00 | 1.00 | |